TRMT5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.44169137633799E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.03859999997813E-06 |
Normal-vs-Stage2 |
9.21370002515687E-09 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62436730732907E-12 |
Stage1-vs-Stage2 |
3.984800E-03 |
Stage1-vs-Stage3 |
6.7873999975987E-08 |
Stage1-vs-Stage4 |
2.21649999465612E-08 |
Stage2-vs-Stage3 |
2.941400E-01 |
Stage2-vs-Stage4 |
8.198400E-02 |
Stage3-vs-Stage4 |
3.832600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.66167080095647E-12 |
Normal-vs-AfricanAmerican |
2.12259999999853E-05 |
Normal-vs-Asian |
4.403400E-03 |
Caucasian-vs-AfricanAmerican |
7.640000E-01 |
Caucasian-vs-Asian |
9.268600E-01 |
AfricanAmerican-vs-Asian |
9.791000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.10462807976364E-15 |
Normal-vs-Female |
2.13160000761548E-09 |
Male-vs-Female |
1.089160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.355100E-04 |
Normal-vs-Age(41-60Yrs) |
7.53839990430549E-10 |
Normal-vs-Age(61-80Yrs) |
1.63558055987778E-12 |
Normal-vs-Age(81-100Yrs) |
1.039030E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.618200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.602000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.814800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.500600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.028400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.451400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.022000E-01 |
Normal-vs-Grade 2 |
1.54070999999201E-05 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.372370E-01 |
Grade 1-vs-Grade 3 |
9.445600E-04 |
Grade 1-vs-Grade 4 |
2.51979999976726E-07 |
Grade 2-vs-Grade 3 |
1.51400000003576E-06 |
Grade 2-vs-Grade 4 |
5.12956344067561E-12 |
Grade 3-vs-Grade 4 |
9.954900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.819400E-04 |
Normal-vs-ccB subtype |
1.11022302462516E-16 |
ccA subtype-vs-ccB subtype |
5.38129996119352E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.4624746686186E-13 |
Normal-vs-N1 |
2.34945396471176E-12 |
N0-vs-N1 |
4.419700E-03 |
|
|